Medline recalls nearly 50K procedure kits, including many used by cardiologists
Medline, the Illinois-based medical supplier that went public in December 2025, has recalled nearly 50,000 procedure kits used in the cardiac cath lab and other parts of the hospital.
The recall was put in place due to a risk of issues with the Mastisol Liquid Adhesive included in these procedure kits. Developed by Ferndale Laboratories, Mastisol is commonly used to secure dressings, tapes and medical devices for long periods of time.
Medline has identified a risk of the adhesive’s packaging cracking, which renders it “unusable for application.”
No kits need to be returned. However, a warning label should be added that tells clinicians to use an alternative adhesive.
Mastisol Liquid Adhesive
The U.S. Food and Drug Administration (FDA) categorized this as a Class II recall, which means using these procedure kits without replacing the adhesive “may cause temporary or medically reversible adverse health consequences.” Medline’s Minor Cath Lab Pack, OR Vascular Angio Pack and Port-a-Cath procedure kits are all included in this recall. Click here for more information about those specific kits from the FDA.
Many other Medline procedure kits used by heart specialists are part of this Class II recall, including the BIB AV Fistula Pack, Cardiac Minor Surgicount Pack, Endovascular Park, EP Device, Full Line Aneurysm CDS, Gen Fem Pop #14-RF, Implant Pack, Open Heart Mrngsd, Pacemaker Pack-LF, Pacemaker Setup Pack, Pacer/Cath Lab Pack-LF, Pacer CDS, Pacer Pack, PK EP Lab Pacemaker and Venous Access Pack procedure kits. Click here for more information about those specific kits.
A full rundown of all procedure kits included in this Class II recall is available here.
Michael has more than 19 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.